Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Cell Stress & Chaperones
|
February 27, 2026
New Allosteric Modulators of Molecular Chaperone TRAP1 from the Integration of Computational Biology, Medicinal Chemistry, and Biophysics
Federica Guarra, Denis Komarov, Andrea Ciamarone, et al.
Journal of Medicinal Chemistry
|
February 11, 2020
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib
Greta Bagnolini, Domenico Milano, Marcella Manerba, et al.
Journal of Medicinal Chemistry
|
April 29, 2026
A Polypharmacology-Driven Approach to Alzheimer's Disease and Tauopathies: Rational Design, Synthesis and Characterization of Amino-Pyrazole-Based Multikinase (GSK-3β/FYN-α/DYRK1A) Inhibitors
Stefania Demuro, Debora Russo, Ilaria Penna, et al.
Nature Communications
|
July 31, 2025
METTL9 sustains vertebrate neural development primarily via non-catalytic functions
Azzurra Codino, Luca Spagnoletti, Claudia Olobardi, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 9, 2022
Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives
Federica Barbieri, Alessia Graziana Bosio, Alessandra Pattarozzi, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 23, 2025
Chronic administration of metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells
Francesca Cianci, Ivan Verduci, Riccardo Cazzoli, et al.
Cell Death Discovery
|
March 17, 2025
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity
Mirco Masi, Laura Poppi, Viola Previtali, et al.
Structure (London, England : 1993)
|
August 26, 2025
Design of multi-target peptide modulators for protein chaperone networks
Luca Torielli, Matteo Castelli, Francesca Milani, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Cell Stress & Chaperones
|
February 27, 2026
New Allosteric Modulators of Molecular Chaperone TRAP1 from the Integration of Computational Biology, Medicinal Chemistry, and Biophysics
Federica Guarra, Denis Komarov, Andrea Ciamarone, et al.
Journal of Medicinal Chemistry
|
February 11, 2020
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib
Greta Bagnolini, Domenico Milano, Marcella Manerba, et al.
Journal of Medicinal Chemistry
|
April 29, 2026
A Polypharmacology-Driven Approach to Alzheimer's Disease and Tauopathies: Rational Design, Synthesis and Characterization of Amino-Pyrazole-Based Multikinase (GSK-3β/FYN-α/DYRK1A) Inhibitors
Stefania Demuro, Debora Russo, Ilaria Penna, et al.
Nature Communications
|
July 31, 2025
METTL9 sustains vertebrate neural development primarily via non-catalytic functions
Azzurra Codino, Luca Spagnoletti, Claudia Olobardi, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 9, 2022
Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives
Federica Barbieri, Alessia Graziana Bosio, Alessandra Pattarozzi, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 23, 2025
Chronic administration of metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells
Francesca Cianci, Ivan Verduci, Riccardo Cazzoli, et al.
Cell Death Discovery
|
March 17, 2025
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity
Mirco Masi, Laura Poppi, Viola Previtali, et al.
Structure (London, England : 1993)
|
August 26, 2025
Design of multi-target peptide modulators for protein chaperone networks
Luca Torielli, Matteo Castelli, Francesca Milani, et al.
Page
of 5